Loading organizations...
§ Private Profile · Cambridge, MA, USA
Clinical-stage oncology company developing CXCR4 antagonists.
X4 Pharmaceuticals has raised $124.5M across 3 funding rounds.
X4 Pharmaceuticals has raised $124.5M in total across 3 funding rounds.
X4 Pharmaceuticals has raised $124.5M across 3 funding rounds. Most recently, it raised $60.0M Other Equity in August 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 12, 2025 | $60M Venture Round | Coastlands Capital | Bain Capital Life Sciences, NEW Enterprise Associates | Announced |
| Nov 16, 2017 | $27M Series B | Bihua Chen | — | Announced |
| Dec 14, 2015 | $37.5M Series A | Cormorant Asset Management | Henri Termeer | Announced |
X4 Pharmaceuticals has raised $124.5M in total across 3 funding rounds.
X4 Pharmaceuticals's investors include Coastlands Capital, Bain Capital Life Sciences, New Enterprise Associates, Bihua Chen, Cormorant Asset Management, Henri Termeer.